BNP Paribas Financial Markets’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,943
| Closed | -$244K | – | 4584 |
|
|
2019
Q3 | $244K | Buy |
12,943
+5,017
| +63% | +$57.4K | ﹤0.01% | 2649 |
|
|
2019
Q2 | $93.3K | Sell |
7,926
-5,615
| -41% | -$68K | ﹤0.01% | 3076 |
|
|
2019
Q1 | $185K | Buy |
13,541
+12,107
| +844% | +$157K | ﹤0.01% | 2753 |
|
|
2018
Q4 | $14.7K | Sell |
1,434
-1,968
| -58% | -$25.2K | ﹤0.01% | 3212 |
|
|
2018
Q3 | $56.6K | Sell |
3,402
-544
| -14% | -$9.83K | ﹤0.01% | 2993 |
|
|
2018
Q2 | $62.3K | Sell |
3,946
-9,646
| -71% | -$147K | ﹤0.01% | 3023 |
|
|
2018
Q1 | $173K | Buy |
13,592
+950
| +8% | +$13.7K | ﹤0.01% | 2881 |
|
|
2017
Q4 | $145K | Buy |
12,642
+5,899
| +87% | +$65.8K | ﹤0.01% | 3119 |
|
|
2017
Q3 | $82.6K | Buy |
6,743
+979
| +17% | +$10.2K | ﹤0.01% | 2888 |
|
|
2017
Q2 | $66K | Buy |
5,764
+4,891
| +560% | +$90.4K | ﹤0.01% | 3046 |
|
|
2017
Q1 | $18.2K | Sell |
873
-615
| -41% | -$13.6K | ﹤0.01% | 3043 |
|
|
2016
Q4 | $30.9K | Sell |
1,488
-2,356
| -61% | -$61.3K | ﹤0.01% | 3027 |
|
|
2016
Q3 | $126K | Buy |
3,844
+2,016
| +110% | +$61.4K | ﹤0.01% | 1989 |
|
|
2016
Q2 | $45.6K | Buy |
+1,828
| New | +$49.5K | ﹤0.01% | 2327 |
|
|
2016
Q1 | – | Sell |
-5,292
| Closed | -$175K | – | 3313 |
|
|
2015
Q4 | $175K | Buy |
5,292
+288
| +6% | +$9.74K | ﹤0.01% | 2028 |
|
|
2015
Q3 | $164K | Buy |
5,004
+3,292
| +192% | +$140K | ﹤0.01% | 2091 |
|
|
2015
Q2 | $90.7K | Buy |
1,712
+1,555
| +990% | +$56.6K | ﹤0.01% | 2132 |
|
|
2015
Q1 | $4.53K | Buy |
+157
| New | +$4.31K | ﹤0.01% | 3210 |
|
|
2014
Q4 | – | Sell |
-452
| Closed | -$5.73K | – | 3599 |
|
|
2014
Q3 | $5.73K | Buy |
+452
| New | +$6.83K | ﹤0.01% | 3785 |
|
BNP Paribas Financial Markets's ALDR Position: Q4 2019 in Review
BNP Paribas Financial Markets sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 12,943 shares — an estimated $244K sold.
BNP Paribas Financial Markets first reported a position in ALDR in Q3 2014 and held it in 19 quarters. The position peaked at $244K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- BNP Paribas Financial Markets reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 12,943 Alder Biopharmaceuticals shares in Q4 2019, an estimated $244K.
- BNP Paribas Financial Markets first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 19 quarters.
- BNP Paribas Financial Markets's Alder Biopharmaceuticals position peaked at $244K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.